Skip to content
Recall Observatory FDA recall evidence

Drug product

SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01

D-0855-2017

February 16, 2017

Class II

Product summary

Firm
Sato Pharmaceutical Inc.
Event
Event 77161
Status
Terminated
Classification
Class II
Quantity
4,790 bottles
Official record key
drug-enforcement:D-0855-2017

Official wording

Reason: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Code information: Lot #: WXWZ, Exp. March 2019; WXTS, Exp. October 2019

Distribution pattern: US: Hawaii, Guam, Saipan, SPI

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility